| For: | Zezos P, Renner EL. Liver transplantation and non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(42): 15532-15538 [PMID: 25400437 DOI: 10.3748/wjg.v20.i42.15532] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i42/15532.htm |
| Number | Citing Articles |
| 1 |
Naftali Presser, Jeffery L. Ponsky. Surgical Procedures on the Cirrhotic Patient. 2017; doi: 10.1007/978-3-319-52396-5_9
|
| 2 |
Peter J. Altshuler, Hien Dang, Adam M. Frank, Ashesh P. Shah, Jaime Glorioso, Tingting Zhan, Arturo Rios Diaz, Osama Shaheen, Carlo B. Ramirez, Warren R. Maley, Adam S. Bodzin. Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic Steatohepatitis. Liver Transplantation 2022; 28(4) doi: 10.1002/lt.26313
|
| 3 |
Suliman Al Humayed. Protective and therapeutic effects ofCrataegus aroniain non-alcoholic fatty liver disease. Archives of Physiology and Biochemistry 2017; 123(1) doi: 10.1080/13813455.2016.1205097
|
| 4 |
Incidence and Predictors of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease. Journal of Clinical and Experimental Hepatology 2023; 13(1) doi: 10.1016/j.jceh.2022.09.007
|
| 5 |
Russell Rosenblatt, Amit Mehta, David Snell, Erika Hissong, Andrea Siobhan Kierans, Sonal Kumar. Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective Analysis. Digestive Diseases and Sciences 2019; 64(1) doi: 10.1007/s10620-018-5295-x
|
| 6 |
Paulo Reis-Júnior, Ryan Tanigawa, Gustavo Heluani Antunes de Mesquita, Natalia Basan, Venâncio Alves, Luiz Augusto Carneiro D'Albuquerque, Wellington Andraus. Steatosis and steatohepatitis found in adults after death due to non-burn trauma. Clinics 2019; 74 doi: 10.6061/clinics/2019/e1070
|
| 7 |
Nadia Al Mazrouei, Mostafa Mohsen ElGharbawy, Mahitab Gamal, Shaimaa Emad, Amal Ahmed Mohamed, Osama Mohamed Ibrahim, Asim Ahmed Elnour, Marafi Jammaa Ahmed, Semira Abdi Beshir, Vineetha Menon, Sami Fatehi Abdalla, Ali Awadallah Saeed, Heba Ali ElRamly, Anna Di Sessa. Evaluating liver type fatty acid binding protein as a diagnostic and prognostic biomarker in metabolic dysfunction-associated steatotic liver disease in pediatric patients. PLOS One 2025; 20(9) doi: 10.1371/journal.pone.0333581
|
| 8 |
Eugenia Tsai, Tai-Ping Lee. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography. Clinics in Liver Disease 2018; 22(1) doi: 10.1016/j.cld.2017.08.004
|
| 9 |
Roberto Pellicciari, Mark Pruzanski, Antimo Gioiello. Successful Drug Discovery. 2018; doi: 10.1002/9783527808694.ch8
|
| 10 |
Elisabete Martins, Ana Oliveira. NAFLD and cardiovascular disease. Porto Biomedical Journal 2018; 3(2) doi: 10.1016/j.pbj.0000000000000002
|
| 11 |
Marium Ahmed, Rabeeya Saeed, Lubna Kamani, Noureen Durrani, Faraz Ahmed. Comparison of fatty liver index with fibroscan in non-alcoholic fatty liver disease. Journal of Family Medicine and Primary Care 2024; 13(4) doi: 10.4103/jfmpc.jfmpc_1789_23
|
| 12 |
Yuxiang Zhang, Romeo Papazyan, Manashree Damle, Bin Fang, Jennifer Jager, Dan Feng, Lindsey C. Peed, Dongyin Guan, Zheng Sun, Mitchell A. Lazar. The hepatic circadian clock fine-tunes the lipogenic response to feeding through RORα/γ. Genes & Development 2017; 31(12) doi: 10.1101/gad.302323.117
|
| 13 |
Madhangi Parameswaran, Hamzah A Hasan, Jafor Sadeque, Sharan Jhaveri, Chaithanya Avanthika, Abimbola E Arisoyin, Maulik B Dhanani, Swaroopa M Rath . Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD). Cureus 2021; doi: 10.7759/cureus.20776
|
| 14 |
Francesco De Chiara, Ainhoa Ferret-Miñana, Juan M. Fernández-Costa, Alice Senni, Rajiv Jalan, Javier Ramón-Azcón. Fatty Hepatocytes Induce Skeletal Muscle Atrophy In Vitro: A New 3D Platform to Study the Protective Effect of Albumin in Non-Alcoholic Fatty Liver. Biomedicines 2022; 10(5) doi: 10.3390/biomedicines10050958
|
| 15 |
Daniela Grimm, Markus Wehland, Thomas J. Corydon, Peter Richter, Binod Prasad, Johann Bauer, Marcel Egli, Sascha Kopp, Michael Lebert, Marcus Krüger. The effects of microgravity on differentiation and cell growth in stem cells and cancer stem cells. Stem Cells Translational Medicine 2020; 9(8) doi: 10.1002/sctm.20-0084
|
| 16 |
Yasuyo Urasaki, Chi Zhang, Ji-Xin Cheng, Thuc T. Le. Quantitative Assessment of Liver Steatosis and Affected Pathways with Molecular Imaging and Proteomic Profiling. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-22082-6
|
| 17 |
M. Pilar Valdecantos, Virginia Pardo, Laura Ruiz, Luis Castro‐Sánchez, Borja Lanzón, Elisa Fernández‐Millán, Carmelo García‐Monzón, Ana I. Arroba, Águeda González‐Rodríguez, Fernando Escrivá, Carmen Álvarez, Francisco J. Rupérez, Coral Barbas, Anish Konkar, Jacqui Naylor, David Hornigold, Ana Dos Santos, Maria Bednarek, Joseph Grimsby, Cristina M. Rondinone, Ángela M. Valverde. A novel glucagon‐like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice. Hepatology 2017; 65(3) doi: 10.1002/hep.28962
|
| 18 |
Atilla Engin. Obesity and Lipotoxicity. Advances in Experimental Medicine and Biology 2017; 960 doi: 10.1007/978-3-319-48382-5_19
|
| 19 |
Pegah Golabi, Haley Bush, Maria Stepanova, Cameron T. Locklear, Ira M. Jacobson, Alita Mishra, Gregory Trimble, Madeline Erario, Chapy Venkatesan, Issah Younossi, Zachary Goodman, Zobair M. Younossi. Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis. Medicine 2018; 97(31) doi: 10.1097/MD.0000000000011518
|
| 20 |
Zhengmao Song, Yun Wang, Pingli Lin, Kaichun Yang, Xilin Jiang, Junchen Dong, Shangjin Xie, Rong Rao, Lishan Cui, Feng Liu, Xuefeng Huang. Identification of key modules and driving genes in nonalcoholic fatty liver disease by weighted gene co-expression network analysis. BMC Genomics 2023; 24(1) doi: 10.1186/s12864-023-09458-3
|
| 21 |
Neeraj K. Saxena, Frank A. Anania. Adipocytokines and hepatic fibrosis. Trends in Endocrinology & Metabolism 2015; 26(3) doi: 10.1016/j.tem.2015.01.002
|
| 22 |
Mei Hua Gao, Dimosthenis Giamouridis, N. Chin Lai, Evelyn Walenta, Vivian Almeida Paschoal, Young Chul Kim, Atsushi Miyanohara, Tracy Guo, Min Liao, Li Liu, Zhen Tan, Theodore P. Ciaraldi, Simon Schenk, Aditi Bhargava, Da Young Oh, H. Kirk Hammond. One-time injection of AAV8 encoding urocortin 2 provides long-term resolution of insulin resistance. JCI Insight 2016; 1(15) doi: 10.1172/jci.insight.88322
|
| 23 |
Nicholas R. L. Lind, Qingwen Qian, Ling Yang. ER Stress and Autophagy in Obesity and Nonalcoholic Fatty Liver Disease. Current Pathobiology Reports 2017; 5(3) doi: 10.1007/s40139-017-0145-7
|
| 24 |
Seo Young Kang, Ye-Jee Kim, Hye Soon Park. Trends in the Prevalence of Non-Alcoholic Fatty Liver Disease and Its Future Predictions in Korean Men, 1998–2035. Journal of Clinical Medicine 2020; 9(8) doi: 10.3390/jcm9082626
|
| 25 |
Sebastian Holländer, Maximilian von Heesen, Gereon Gäbelein, Julie Mercier, Matthias W. Laschke, Antonios Spiliotis, Mirza Alic, Matthias Glanemann. Pharmacological preconditioning with cilostazol reverses steatosis and protects the liver against ischemia-reperfusion injury in steatotic rats. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-70871-1
|
| 26 |
Swapna Chaturvedi, Divya Tripathi, Naval Kishore Vikram, Kumble S. Madhusudan, Ravindra Pandey, Neena Bhatia. Association of Nutrient Intake with Non-Alcoholic Fatty Liver Disease and Liver Steatosis in Adult Indian Population –A Case Control Study. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4131079
|
| 27 |
Ye Fan, Chao Yang, Jintong Pan, Wei Ye, Jinmeng Zhang, Rong Zeng, Zaohong Chen, Xiang Liu. A new target for curcumin in the treatment of non-alcoholic fatty liver disease: the FTO protein. International Journal of Biological Macromolecules 2025; 319 doi: 10.1016/j.ijbiomac.2025.145642
|
| 28 |
Ivy K.M. Law, Michelle W. Cheng, David Q. Shih, Dermot P.B. McGovern, Hon Wai Koon. Antimicrobial Peptides in Gastrointestinal Diseases. 2018; doi: 10.1016/B978-0-12-814319-3.00003-9
|
| 29 |
Ulf Kulik, Frank Lehner, Jürgen Klempnauer, Jürgen Borlak. Primary non‐function is frequently associated with fatty liver allografts and high mortality after re‐transplantation. Liver International 2017; 37(8) doi: 10.1111/liv.13404
|
| 30 |
Christopher D. Anderson. Liver Transplantation for NASH-Related Cirrhosis. Current Surgery Reports 2015; 3(8) doi: 10.1007/s40137-015-0101-6
|
| 31 |
Pengcheng Peter Zhang, Hailey H. Choi, Michael A. Ohliger. Detection of fatty liver using virtual non-contrast dual-energy CT. Abdominal Radiology 2022; 47(6) doi: 10.1007/s00261-022-03482-9
|
| 32 |
Diptadip Dattaroy, Ratanesh Kumar Seth, Sutapa Sarkar, Diana Kimono, Muayad Albadrani, Varun Chandrashekaran, Firas Al Hasson, Udai P. Singh, Daping Fan, Mitzi Nagarkatti, Prakash Nagarkatti, Anna Mae Diehl, Saurabh Chatterjee. Sparstolonin B (SsnB) attenuates liver fibrosis via a parallel conjugate pathway involving P53-P21 axis, TGF-beta signaling and focal adhesion that is TLR4 dependent. European Journal of Pharmacology 2018; 841 doi: 10.1016/j.ejphar.2018.08.040
|
| 33 |
Swapna Chaturvedi, Divya Tripathi, Naval Kishore Vikram, Kumble S. Madhusudan, Ravindra Mohan Pandey, Neena Bhatia. Association of nutrient intake with non-alcoholic fatty liver disease and liver steatosis in adult Indian population – A case control study. Human Nutrition & Metabolism 2023; 32 doi: 10.1016/j.hnm.2023.200188
|
| 34 |
Isabel Baik, Arin Jantz, Adina Poparad‐Stezar, Deepak Venkat, Nadeen Khoury, Milagros Samaniego‐Picota, Humberto C. Gonzalez, Mary Grace Fitzmaurice. Evaluating the use of glucagon‐like peptide‐1 receptor agonists in a matched cohort of kidney and liver transplant recipients. Journal of Pharmacy Practice and Research 2025; 55(2) doi: 10.1002/jppr.1953
|
| 35 |
Hedyeh Ebrahimi, Mohammadreza Naderian, Amir Ali Sohrabpour. New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article. Middle East Journal of Digestive Diseases 2016; 8(3) doi: 10.15171/mejdd.2016.29
|
| 36 |
Bo-kyeong Kang, Mimi Kim, Soon-young Song, Dae won Jun, Kiseok Jang. Feasibility of modified Dixon MRI techniques for hepatic fat quantification in hepatic disorders: validation with MRS and histology. The British Journal of Radiology 2017; 91(1089) doi: 10.1259/bjr.20170378
|
| 37 |
Samir Softic, David E. Cohen, C. Ronald Kahn. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease. Digestive Diseases and Sciences 2016; 61(5) doi: 10.1007/s10620-016-4054-0
|
| 38 |
Shujie Lai, Yan Li, Yi Kuang, Hongli Cui, Yang Yang, Wenjing Sun, Kaijun Liu, Dongfeng Chen, Qixian Yan, Liangzhi Wen. PKCδ silencing alleviates saturated fatty acid induced ER stress by enhancing SERCA activity. Bioscience Reports 2017; 37(6) doi: 10.1042/BSR20170869
|
| 39 |
Liyun Yuan, Courtney L. Hanlon, Norah Terrault, Saleh Alqahtani, Hani Tamim, Michelle Lai, Behnam Saberi. Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States. American Journal of Gastroenterology 2022; 117(3) doi: 10.14309/ajg.0000000000001591
|
| 40 |
Atilla Engin. Obesity and Lipotoxicity. Advances in Experimental Medicine and Biology 2024; 1460 doi: 10.1007/978-3-031-63657-8_18
|
| 41 |
Elizabeth L. Yu, Hyeri You, Bryan Rudolph, Jennifer A. Panganiban, Taisa J. Kohut, Henry C. Lin, Amanda C. Fifi, Rasmita Budhathoki, Megan W. Butler, Sabina R. Anderson, Nidhi P. Goyal, Kimberly P. Newton, Jeffrey B. Schwimmer. Patient perspective on exercise practices, preferences, and barriers in pediatric nonalcoholic fatty liver disease: A multicenter survey. JPGN Reports 2024; 5(3) doi: 10.1002/jpr3.12072
|
| 42 |
Nicholas N. Nissen, Alagappan Annamalai, Andrew Klein. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. 2019; doi: 10.1016/B978-0-323-40232-3.00127-8
|
| 43 |
Veeravich Jaruvongvanich, Anawin Sanguankeo, Sikarin Upala. Nonalcoholic Fatty Liver Disease Is Not Associated with Thyroid Hormone Levels and Hypothyroidism: A Systematic Review and Meta-Analysis. European Thyroid Journal 2017; 6(4) doi: 10.1159/000454920
|
| 44 |
Andrew S. Barbas, Nicolas Goldaracena, Martin J. Dib, David P. Al-Adra, Aloysious D. Aravinthan, Leslie B. Lilly, Eberhard L. Renner, Nazia Selzner, Mamatha Bhat, Mark S. Cattral, Anand Ghanekar, Ian D. McGilvray, Gonzalo Sapisochin, Markus Selzner, Paul D. Greig, David R. Grant. Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto Experience. Transplantation Direct 2017; 3(6) doi: 10.1097/TXD.0000000000000674
|
| 45 |
Jing Gao, Isain Zapata, Johnson Chen, Todd N. Erpelding, Colby Adamson, David Park. Quantitative Ultrasound Biomarkers to Assess Nonalcoholic Fatty Liver Disease. Journal of Ultrasound in Medicine 2023; 42(8) doi: 10.1002/jum.16185
|
| 46 |
D Hoang-Yen Tran, D Hoang-Ngoc Tran, S A Mattai, T Sallam, C Ortiz, E C Lee, L Robbins, S Ho, J E Lee, E Fisseha, C Shieh, A Sideri, D Q Shih, P Fleshner, D P B McGovern, M Vu, T C Hing, K Bakirtzi, M Cheng, B Su, I Law, I Karagiannides, S R Targan, R L Gallo, Z Li, H W Koon. Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor. International Journal of Obesity 2016; 40(9) doi: 10.1038/ijo.2016.90
|
| 47 |
Abigail Wolf Greenstein, Neena Majumdar, Peng Yang, Papasani V Subbaiah, Rhonda D Kineman, Jose Cordoba-Chacon. Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice. Journal of Endocrinology 2017; 232(1) doi: 10.1530/JOE-16-0447
|
| 48 |
Said A. Al-Busafi, Mohammed Eslam. Liver Transplantation in the Era of Metabolic Dysfunction–Associated Fatty Liver Disease: Challenges, Ethical Dilemmas, and Future Directions. Transplantology 2025; 6(4) doi: 10.3390/transplantology6040035
|
| 49 |
. 2019; doi: 10.70675/aaef06b8z77e8z42ccz929cz1f7b59bd4414
|
| 50 |
Jeremy Van, Costica Aloman, Nancy Reau. Potential Bias and Misconceptions in Liver Transplantation for Alcohol- and Obesity-Related Liver Disease. American Journal of Gastroenterology 2021; 116(10) doi: 10.14309/ajg.0000000000001349
|
| 51 |
Naga Chalasani, Zobair Younossi, Joel E. Lavine, Michael Charlton, Kenneth Cusi, Mary Rinella, Stephen A. Harrison, Elizabeth M. Brunt, Arun J. Sanyal. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018; 67(1) doi: 10.1002/hep.29367
|
| 52 |
|
| 53 |
Fernando Ezquer, Javiera Bahamonde, Ya-Lin Huang, Marcelo Ezquer. Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy. Stem Cell Research & Therapy 2017; 8(1) doi: 10.1186/s13287-016-0469-y
|
| 54 |
Mary Ellen Vajravelu, Emir Tas, Silva Arslanian. Pediatric Obesity: Complications and Current Day Management. Life 2023; 13(7) doi: 10.3390/life13071591
|
| 55 |
Benedikt Kaufmann, Agustina Reca, Baocai Wang, Helmut Friess, Ariel E. Feldstein, Daniel Hartmann. Mechanisms of nonalcoholic fatty liver disease and implications for surgery. Langenbeck's Archives of Surgery 2021; 406(1) doi: 10.1007/s00423-020-01965-1
|
| 56 |
|
| 57 |
Yuval A. Patel, Carl L. Berg, Cynthia A. Moylan. Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation. Digestive Diseases and Sciences 2016; 61(5) doi: 10.1007/s10620-016-4035-3
|
| 58 |
Hyoung-Yun Han, Sung-Kwon Lee, Bong-Keun Choi, Dong-Ryung Lee, Hae Jin Lee, Tae-Won Kim. Preventive Effect of <i>Citrus aurantium</i> Peel Extract on High-Fat Diet-Induced Non-alcoholic Fatty Liver in Mice. Biological and Pharmaceutical Bulletin 2019; 42(2) doi: 10.1248/bpb.b18-00702
|
| 59 |
Tomasz Charytoniuk, Krzysztof Drygalski, Karolina Konstantynowicz-Nowicka, Klaudia Berk, Adrian Chabowski. Alternative treatment methods attenuate the development of NAFLD: A review of resveratrol molecular mechanisms and clinical trials. Nutrition 2017; 34 doi: 10.1016/j.nut.2016.09.001
|
| 60 |
Izna Ali, Jason R. Slizgi, Josh D. Kaullen, Marija Ivanovic, Mikko Niemi, Paul W. Stewart, Alfred S. Barritt, Kim L.R. Brouwer. Transporter‐Mediated Alterations in Patients With NASH Increase Systemic and Hepatic Exposure to an OATP and MRP2 Substrate. Clinical Pharmacology & Therapeutics 2018; 104(4) doi: 10.1002/cpt.997
|
| 61 |
Myriam Alexander, A. Katrina Loomis, Jolyon Fairburn-Beech, Johan van der Lei, Talita Duarte-Salles, Daniel Prieto-Alhambra, David Ansell, Alessandro Pasqua, Francesco Lapi, Peter Rijnbeek, Mees Mosseveld, Paul Avillach, Peter Egger, Stuart Kendrick, Dawn M. Waterworth, Naveed Sattar, William Alazawi. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease. BMC Medicine 2018; 16(1) doi: 10.1186/s12916-018-1103-x
|
| 62 |
Thomas Berg, Niklas F. Aehling, Tony Bruns, Martin-Walter Welker, Tobias Weismüller, Jonel Trebicka, Frank Tacke, Pavel Strnad, Martina Sterneck, Utz Settmacher, Daniel Seehofer, Eckart Schott, Andreas Anton Schnitzbauer, Hartmut H. Schmidt, Hans J. Schlitt, Johann Pratschke, Andreas Pascher, Ulf Neumann, Steffen Manekeller, Frank Lammert, Ingo Klein, Gabriele Kirchner, Markus Guba, Matthias Glanemann, Cornelius Engelmann, Ali E. Canbay, Felix Braun, Christoph P. Berg, Wolf O. Bechstein, Thomas Becker, Christian Trautwein. S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV). Zeitschrift für Gastroenterologie 2024; 62(09) doi: 10.1055/a-2255-7246
|
| 63 |
Ana I. Álvarez-Mercado, Elsa Negrete-Sánchez, José Gulfo, Cindy G. Ávalos de León, Araní Casillas-Ramírez, María Eugenia Cornide-Petronio, Esther Bujaldon, Floriana Rotondo, Jordi Gracia-Sancho, Mónica B. Jiménez-Castro, Carmen Peralta. EGF-GH Axis in Rat Steatotic and Non-steatotic Liver Transplantation From Brain-dead Donors. Transplantation 2019; 103(7) doi: 10.1097/TP.0000000000002636
|
| 64 |
Bei Li, Chuan Zhang, Yu-Tao Zhan. Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis. Canadian Journal of Gastroenterology and Hepatology 2018; 2018 doi: 10.1155/2018/2784537
|
| 65 |
Shohei Narita, Satoshi Miuma, Sadayuki Okudaira, Yoshito Koga, Masanori Fukushima, Ryu Sasaki, Masafumi Haraguchi, Akihiko Soyama, Masaaki Hidaka, Hisamitsu Miyaaki, Mitsuru Futakuchi, Kazuhiro Nagai, Tatsuki Ichikawa, Susumu Eguchi, Kazuhiko Nakao. Regular protocol liver biopsy is useful to adjust immunosuppressant dose after adult liver transplantation. Clinical Transplantation 2023; 37(3) doi: 10.1111/ctr.14873
|
| 66 |
Mariabeatrice Principi, Andrea Iannone, Giuseppe Losurdo, Michela Mangia, Endrit Shahini, Francesca Albano, Salvatore Fabio Rizzi, Rosa Federica La Fortezza, Rosa Lovero, Antonella Contaldo, Michele Barone, Gioacchino Leandro, Enzo Ierardi, Alfredo Di Leo. Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors. Inflammatory Bowel Diseases 2018; 24(7) doi: 10.1093/ibd/izy051
|
| 67 |
C. Lynch, C. S. Chan, A. J. Drake. Early life programming and the risk of non-alcoholic fatty liver disease. Journal of Developmental Origins of Health and Disease 2017; 8(3) doi: 10.1017/S2040174416000805
|
| 68 |
Lindsay D. Plank, Kylie Russell. Nutrition in liver transplantation. Current Opinion in Clinical Nutrition and Metabolic Care 2015; 18(5) doi: 10.1097/MCO.0000000000000205
|
| 69 |
Daryl Ramai, Waqqas Tai, Michelle Rivera, Antonio Facciorusso, Nicola Tartaglia, Mario Pacilli, Antonio Ambrosi, Christian Cotsoglou, Rodolfo Sacco. Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma. Biomedicines 2021; 9(2) doi: 10.3390/biomedicines9020184
|
| 70 |
Ajay C Donepudi, Gregory J Smith, Oladimeji Aladelokun, Yoojin Lee, Steven J Toro, Marisa Pfohl, Angela L Slitt, Li Wang, Ji-Young Lee, John D Schuetz, José E Manautou. Lack of Multidrug Resistance-associated Protein 4 Prolongs Partial Hepatectomy-induced Hepatic Steatosis. Toxicological Sciences 2020; 175(2) doi: 10.1093/toxsci/kfaa032
|
| 71 |
Kasper Ter Horst, Mireille Serlie. Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease. Nutrients 2017; 9(9) doi: 10.3390/nu9090981
|
| 72 |
Naomi Fleury, Sian Geldenhuys, Shelley Gorman. Sun Exposure and Its Effects on Human Health: Mechanisms through Which Sun Exposure Could Reduce the Risk of Developing Obesity and Cardiometabolic Dysfunction. International Journal of Environmental Research and Public Health 2016; 13(10) doi: 10.3390/ijerph13100999
|
| 73 |
Aaryani Tipirneni-Sajja, Sarah Brasher, Utsav Shrestha, Hayden Johnson, Cara Morin, Sanjaya K. Satapathy. Quantitative MRI of diffuse liver diseases: techniques and tissue-mimicking phantoms. Magnetic Resonance Materials in Physics, Biology and Medicine 2022; 36(4) doi: 10.1007/s10334-022-01053-z
|
| 74 |
. 2022; doi: 10.70675/1716f226z5188z4febz8ff5z973e59906619
|
| 75 |
Antonella Mosca, Silvio Veraldi, Andrea Dellostrologo, Mariateresa Sanseviero, Valerio Nobili. Pediatric Hepatology and Liver Transplantation. 2019; doi: 10.1007/978-3-319-96400-3_17
|
| 76 |
S. Hsieh, B. P. Leaderer, A. E. Feldstein, N. Santoro, L. A. McKay, S. Caprio, R. McConnell. Traffic‐related air pollution associations with cytokeratin‐18, a marker of hepatocellular apoptosis, in an overweight and obese paediatric population. Pediatric Obesity 2018; 13(6) doi: 10.1111/ijpo.12228
|
| 77 |
Michelle L. Aktary, Lindsay K. Eller, Alissa C. Nicolucci, Raylene A. Reimer. Cross-sectional analysis of the health profile and dietary intake of a sample of Canadian adults diagnosed with non-alcoholic fatty liver disease. Food & Nutrition Research 2020; 64(0) doi: 10.29219/fnr.v64.4548
|
| 78 |
Yuhi Shimura, Kaori Kuramitsu, Masahiro Kido, Shohei Komatsu, Hidetoshi Gon, Kenji Fukushima, Takeshi Urade, Shinichi So, Toshihiko Yoshida, Keisuke Arai, Daisuke Tsugawa, Tadahiro Goto, Sadaki Asari, Hiroaki Yanagimoto, Hirochika Toyama, Tetsuo Ajiki, Takumi Fukumoto. Factors Predicting Over-Time Weight Increase After Liver Transplantation: A Retrospective Study. Transplantation Proceedings 2023; 55(4) doi: 10.1016/j.transproceed.2023.03.045
|
| 79 |
Sharif Alhajlah. Effect of grape‐derived products on the serum levels of enzymes mainly produced by the liver: A systematic review and meta‐analysis of parallel randomized controlled trials. Phytotherapy Research 2024; 38(7) doi: 10.1002/ptr.8226
|
| 80 |
Xiao-Long He, Li-Ting Wang, Xiang-Zhong Gu, Jie-Xin Xiao, Wen-Wei Qiu. A facile synthesis of ursodeoxycholic acid and obeticholic acid from cholic acid. Steroids 2018; 140 doi: 10.1016/j.steroids.2018.10.009
|
| 81 |
Utsav Shrestha, Marie van der Merwe, Nirman Kumar, Eddie Jacobs, Sanjaya K. Satapathy, Cara Morin, Aaryani Tipirneni‐Sajja. Morphological characterization of hepatic steatosis and Monte Carlo modeling of MRI signal for accurate quantification of fat fraction and relaxivity. NMR in Biomedicine 2021; 34(6) doi: 10.1002/nbm.4489
|
| 82 |
Steve M. Nelson, Jason D. Hoskins, Christopher Lisanti, Jayanta Chaudhuri. Ultrasound Fatty Liver Indicator: A Simple Tool for Differentiating Steatosis From Nonalcoholic Steatohepatitis: Validity in the Average Obese Population. Journal of Ultrasound in Medicine 2020; 39(4) doi: 10.1002/jum.15154
|
| 83 |
Thomas Jensen, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau, Shelby Sullivan. Clinical workup of fatty liver for the primary care provider. Postgraduate Medicine 2019; 131(1) doi: 10.1080/00325481.2019.1546532
|
| 84 |
Meaghan Phipps, Alyson N. Fox, Robert S. Brown. Schiff's Diseases of the Liver. 2017; doi: 10.1002/9781119251316.ch41
|
| 85 |
Annie J. Kruger, Bryan C. Fuchs, Ricard Masia, Jacinta A. Holmes, Shadi Salloum, Mozhdeh Sojoodi, Diego S. Ferreira, Stephanie M. Rutledge, Peter Caravan, Nadia Alatrakchi, Pam Vig, Eric Lefebvre, Raymond T. Chung. Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet‐induced mouse model of nonalcoholic steatohepatitis. Hepatology Communications 2018; 2(5) doi: 10.1002/hep4.1160
|
| 86 |
Muhanad Elhafiz, Guolin Zhao, Mohammed Ismail, Dengqiu Xu, Debanjan Das, Sisi Fan, Nong Cheng, Bashir A. Yousef, Zhenzhou Jiang, Luyong Zhang. Imbalanced insulin substrate-1 and insulin substrate-2 signaling trigger hepatic steatosis in vitamin D deficient rats: 8-methoxypsoralen, a vitamin D receptor ligand with a promising anti-steatotic action. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(6) doi: 10.1016/j.bbalip.2020.158657
|
| 87 |
Love Sharma, Divya Gupta, Sheikh Tasduq Abdullah. Thioacetamide potentiates high cholesterol and high fat diet induced steato-hepatitic changes in livers of C57BL/6J mice: A novel eight weeks model of fibrosing NASH. Toxicology Letters 2019; 304 doi: 10.1016/j.toxlet.2019.01.001
|
| 88 |
Andrea Bell, Soheila Korourian, Huawei Zeng, Joshua Phelps, Reza Hakkak. A diet containing a high- versus low-daidzein level does not protect against liver steatosis in the obese Zucker rat model. Food & Function 2017; 8(3) doi: 10.1039/C6FO01772J
|
| 89 |
Damiano Patrono, Silvia Martini, Renato Romagnoli. Non-Alcoholic Fatty Liver Disease. 2020; doi: 10.1007/978-3-319-95828-6_19
|
| 90 |
D. V. Sidorenko, V. D. Nazarov, S. V. Lapin, V. L. Emanuel. Role of molecular genetic factors in pathogenesis and diagnosis of non-alcoholic fatty liver disease (literature review and own data). Medical alphabet 2020; (5) doi: 10.33667/2078-5631-2020-5-13-19
|
| 91 |
Chiara Saponaro, Melania Gaggini, Amalia Gastaldelli. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms. Current Diabetes Reports 2015; 15(6) doi: 10.1007/s11892-015-0607-4
|
| 92 |
Melissa Palmer, Lee Jennings, Debra G. Silberg, Caleb Bliss, Patrick Martin. A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis. BMC Pharmacology and Toxicology 2018; 19(1) doi: 10.1186/s40360-018-0200-y
|
| 93 |
Rhonda D. Kineman, Neena Majumdar, Papasani V. Subbaiah, Jose Cordoba-Chacon. Hepatic PPARγ Is Not Essential for the Rapid Development of Steatosis After Loss of Hepatic GH Signaling, in Adult Male Mice. Endocrinology 2016; 157(5) doi: 10.1210/en.2015-2077
|
| 94 |
Frank T. Spradley, Jillian A. Smith, Barbara T. Alexander, Christopher D. Anderson. Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease. American Journal of Physiology-Endocrinology and Metabolism 2018; 315(5) doi: 10.1152/ajpendo.00394.2017
|
| 95 |
Isabel Molwitz, Graeme Michael Campbell, Jin Yamamura, Tobias Knopp, Klaus Toedter, Roland Fischer, Zhiyue Jerry Wang, Alina Busch, Ann-Kathrin Ozga, Shuo Zhang, Thomas Lindner, Florian Sevecke, Mirco Grosser, Gerhard Adam, Patryk Szwargulski. Fat Quantification in Dual-Layer Detector Spectral Computed Tomography. Investigative Radiology 2022; 57(7) doi: 10.1097/RLI.0000000000000858
|
| 96 |
Fumiaki Beppu, Haoqi Li, Kazuaki Yoshinaga, Toshiharu Nagai, Akihiko Yoshinda, Atsushi Kubo, Jota Kanda, Naohiro Gotoh. Dietary Starfish Oil Prevents Hepatic Steatosis and Hyperlipidemia in C57BL/6N Mice Fed High-fat Diet. Journal of Oleo Science 2017; 66(7) doi: 10.5650/jos.ess17038
|
| 97 |
Andrew D. Posner, Samuel T. Sultan, Norann A. Zaghloul, William S. Twaddell, David A. Bruno, Steven I. Hanish, William R. Hutson, Laci Hebert, Rolf N. Barth, John C. LaMattina. Resolution of donor non‐alcoholic fatty liver disease following liver transplantation. Clinical Transplantation 2017; 31(9) doi: 10.1111/ctr.13032
|
| 98 |
Mary Chandrika Anton, B. Shanthi, Chaganti Sridevi. Prevalence of Non-Alcoholic Fatty Liver Disease in Urban Adult Population in a Tertiary Care Center, Chennai. Indian Journal of Community Medicine 2023; 48(4) doi: 10.4103/ijcm.ijcm_437_22
|
| 99 |
Abhijit Chowdhury, Zobair M. Younossi. Alcoholic and Non-Alcoholic Fatty Liver Disease. 2016; doi: 10.1007/978-3-319-20538-0_2
|
| 100 |
Zobair M. Younossi. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation. Liver Transplantation 2018; 24(2) doi: 10.1002/lt.25003
|
| 101 |
Yang Ji, Yingmin Liang, Judith C.W. Mak, Mary S.M. Ip. Obstructive sleep apnea, intermittent hypoxia and non-alcoholic fatty liver disease. Sleep Medicine 2022; 95 doi: 10.1016/j.sleep.2022.04.006
|
| 102 |
Michael Karin. New insights into the pathogenesis and treatment of non-viral hepatocellular carcinoma: a balancing act between immunosuppression and immunosurveillance. Precision Clinical Medicine 2018; 1(1) doi: 10.1093/pcmedi/pby005
|
| 103 |
Thomas G. Cotter, Michael Charlton. Nonalcoholic Steatohepatitis After Liver Transplantation. Liver Transplantation 2020; 26(1) doi: 10.1002/lt.25657
|
| 104 |
Mohammadreza Naderian, Heshmatollah Akbari, Morteza Saeedi, Amir Ali Sohrabpour. olyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial. Middle East Journal of Digestive Diseases 2017; 9(1) doi: 10.15171/mejdd.2016.46
|
| 105 |
Raphael Chevre, Laia Trigueros‐Motos, David Castaño, Tricia Chua, Maria Corlianò, Jay V. Patankar, Lareina Sng, Lauren Sim, Tan Liang Juin, Guillaume Carissimo, Lisa F. P. Ng, Cheryl Neo Jia Yi, Chelsea Chandani Eliathamby, Albert K. Groen, Michael R. Hayden, Roshni R. Singaraja. Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice. The FASEB Journal 2018; 32(7) doi: 10.1096/fj.201701084RR
|
| 106 |
Marine Dubois, Maxime Ronot, Pauline Houssel-Debry, Vanessa Brun, Michel Rayar, Magali Auger, Luc Beuzit, Bruno Turlin, Christophe Aubé, Anita Paisant. Performance of B-mode ratio and 2D shear wave elastography for the detection and quantification of hepatic steatosis and fibrosis after liver transplantation. European Journal of Gastroenterology & Hepatology 2020; 32(2) doi: 10.1097/MEG.0000000000001500
|
| 107 |
Seyed Reza Modares Mousavi, Bita Geramizadeh, Amir Anushiravani, Fardad Ejtehadi, Mohammad Hossein Anbardar, Maryam Moini. Correlation between Serum Ferritin Level and Histopathological Disease Severity in Non-alcoholic Fatty Liver Disease. Middle East Journal of Digestive Diseases 2018; 10(2) doi: 10.15171/mejdd.2018.96
|
| 108 |
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities,
and Management of Non-alcoholic Fatty Liver Disorder. Current Drug Therapy 2024; 19(1) doi: 10.2174/1574885518666230417111247
|
| 109 |
Poredoš P, Schernthaner GH, Blinc A, Mikhailidis DP, Jensterle M, Anagnostis P, Antignani PL, Bajuk Studen K, Šabović M, Ježovnik MK. Endocrine Disorders and Peripheral Arterial Disease – A Series of Reviews
Cushing Syndrome-Cortisol Excess. Current Vascular Pharmacology 2024; 22(4) doi: 10.2174/0115701611272145231106053914
|
| 110 |
Anandhu Krishnan G, Rajsekar C S, Srikanth Moorthy, Rubalakshmi S, Saitheja Paidipelly, Sanju Sherji, Fifiya.K. Yusuf. HEPATIC STEATOSIS IN LIVER DONORS: A COMPARATIVE STUDY BETWEEN COMPUTED TOMOGRAPHY AND MAGNETIC RESONANCE IMAGING – PROTON DENSITY FAT FRACTION BASED HEPATIC FAT GRADINGS.. INDIAN JOURNAL OF APPLIED RESEARCH 2021; doi: 10.36106/ijar/1801854
|
| 111 |
Nina Gyorfi, Akos Odry, Zoltan Karadi, Peter Odry, Tibor Szakall, Bojan Kuljic, Attila Toth, Zoltan Vizvari. Development of Bioimpedance-based Measuring Systems for Diagnosis of Non-alcoholic Fatty Liver Disease. 2021 IEEE 15th International Symposium on Applied Computational Intelligence and Informatics (SACI) 2021; doi: 10.1109/SACI51354.2021.9465584
|
| 112 |
Marco Antonio Loera-Torres, Katya Cárdenas-Zurita, Eduardo Ríos-García, Eira Cerda-Reyes, José Antonio Morales-González. Papel de Nrf2 y estrés oxidativo en la progresión de esteatohepatitis no alcohólica a hepatocarcinoma. Cirujano General 2022; 44(1) doi: 10.35366/109314
|
| 113 |
Penglei Ge, Huayu Yang, Jingfen Lu, Wenjun Liao, Shunda Du, Yingli Xu, Haifeng Xu, Haitao Zhao, Xin Lu, Xinting Sang, Shouxian Zhong, Jiefu Huang, Yilei Mao. Albumin Binding Function: The Potential Earliest Indicator for Liver Function Damage. Gastroenterology Research and Practice 2016; 2016 doi: 10.1155/2016/5120760
|
| 114 |
Sharma Love, Malik A. Mudasir, Subhash C. Bhardwaj, Gurdarshan Singh, Sheikh A. Tasduq. Long-term administration of tacrolimus and everolimus prevents high cholesterol-high fructose-induced steatosis in C57BL/6J mice by inhibiting de-novo lipogenesis. Oncotarget 2017; 8(69) doi: 10.18632/oncotarget.15194
|
| 115 |
Max M. Puthenpura, Vishal Patel, John Fam, Leon Katz, David S. Tichansky, Stephan Myers. The Use of Transient Elastography Technology in the Bariatric Patient: a Review of the Literature. Obesity Surgery 2020; 30(12) doi: 10.1007/s11695-020-05002-4
|
| 116 |
John Vizuete, Alfredo Camero, Mazyar Malakouti, Karthik Garapati, Julio Gutierrez. Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies. Journal of Clinical and Translational Hepatology 2017; 5(1) doi: 10.14218/JCTH.2016.00061
|
| 117 |
John Guirguis, Jagpreet Chhatwal, Jaividhya Dasarathy, John Rivas, David McMichael, Laura E. Nagy, Arthur J. McCullough, Srinivasan Dasarathy. Clinical Impact of Alcohol‐Related Cirrhosis in the Next Decade: Estimates Based on Current Epidemiological Trends in the United States. Alcoholism: Clinical and Experimental Research 2015; 39(11) doi: 10.1111/acer.12887
|
| 118 |
Livhuwani P. Nendouvhada, Nicole R. S. Sibuyi, Adewale O. Fadaka, Samantha Meyer, Abram M. Madiehe, Mervin Meyer, Kwazikwakhe B. Gabuza. Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences 2024; 25(11) doi: 10.3390/ijms25115571
|
| 119 |
Jiantao Ma, Shih-Jen Hwang, Alison Pedley, Joseph M. Massaro, Udo Hoffmann, Raymond T. Chung, Emelia J. Benjamin, Daniel Levy, Caroline S. Fox, Michelle T. Long. Bi-directional analysis between fatty liver and cardiovascular disease risk factors. Journal of Hepatology 2017; 66(2) doi: 10.1016/j.jhep.2016.09.022
|
| 120 |
Abbas Ali Tasneem, Nasir Hassan Luck, Zain Majid. Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). Tropical Doctor 2018; 48(2) doi: 10.1177/0049475517742261
|
| 121 |
Sonali Paul, Michael Charlton. Surgical Issues in NASH: Bariatric Surgery and Liver Transplantation. Current Hepatology Reports 2018; 17(4) doi: 10.1007/s11901-018-0429-3
|
| 122 |
John T. Rose, Paola Vargas, Tara Seay, Arthur J. Pesch, Tessa Williams, Anita Sites, Zachary Henry, Patrick G. Northup, Shawn J. Pelletier, Jose Oberholzer, Curtis K. Argo, Nicolas Goldaracena. Lose Weight to Donate: Development of a Program to Optimize Potential Donors With Hepatic Steatosis or Obesity for Living Liver Donation. Transplantation Direct 2021; 7(6) doi: 10.1097/TXD.0000000000001161
|
| 123 |
Jonathan A. Dranoff. Coffee as chemoprotectant in fatty liver disease: caffeine-dependent and caffeine-independent effects. American Journal of Physiology-Gastrointestinal and Liver Physiology 2023; 324(6) doi: 10.1152/ajpgi.00026.2023
|
| 124 |
|
| 125 |
Alabagi Abdulla, Charity Reynolds, H Hesham A-Kader. Non-Alcoholic Fatty Liver Disease (NAFLD): The Search for a Cure. European Medical Journal 2016; doi: 10.33590/emj/10314771
|
| 126 |
Shen-ping Tang, Xin-li Mao, Ya-hong Chen, Ling-ling Yan, Li-ping Ye, Shao-wei Li. Reactive Oxygen Species Induce Fatty Liver and Ischemia-Reperfusion Injury by Promoting Inflammation and Cell Death. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.870239
|
| 127 |
Kazuyoshi Kon, Kenichi Ikejima, Maki Morinaga, Hiromi Kusama, Kumiko Arai, Tomonori Aoyama, Akira Uchiyama, Shunhei Yamashina, Sumio Watanabe. L‐carnitine prevents metabolic steatohepatitis in obese diabetic KK‐Ay mice. Hepatology Research 2017; 47(3) doi: 10.1111/hepr.12720
|
| 128 |
Warinda Susutlertpanya, Hirokazu Wakuda, Naoyuki Otani, Takuya Kuramoto, Li Li, Masae Kuranari, Ai Sekiguchi, Hideo Kudo, Tomohisa Uchida, Hiromitsu Imai, Naoto Uemura. Histological evaluation of nintedanib in non-alcoholic steatohepatitis mice. Life Sciences 2019; 228 doi: 10.1016/j.lfs.2019.05.014
|
| 129 |
Ivana Mikolasevic, Tajana Filipec-Kanizaj, Maja Mijic, Ivan Jakopcic, Sandra Milic, Irena Hrstic, Nikola Sobocan, Davor Stimac, Patrizia Burra. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?. World Journal of Gastroenterology 2018; 24(14): 1491-1506 doi: 10.3748/wjg.v24.i14.1491
|
| 130 |
Zheng-Tao Liu, Tian-Chi Chen, Xiao-Xiao Lu, Jun Cheng, Hai-Yang Xie, Lin Zhou, Shu-Sen Zheng. PNPLA3 I148M variant affects non-alcoholic fatty liver disease in liver transplant recipients. World Journal of Gastroenterology 2015; 21(34): 10054-10056 doi: 10.3748/wjg.v21.i34.10054
|
| 131 |
G. Losurdo, A. Castellaneta, M. Rendina, S. Carparelli, G. Leandro, A. Di Leo. Systematic review with meta‐analysis: de novo non‐alcoholic fatty liver disease in liver‐transplanted patients. Alimentary Pharmacology & Therapeutics 2018; 47(6) doi: 10.1111/apt.14521
|
| 132 |
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 2016; 65(8) doi: 10.1016/j.metabol.2016.05.003
|
| 133 |
Chan Wah Kheong, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology 2017; 15(12) doi: 10.1016/j.cgh.2017.04.016
|
| 134 |
Rohan C. Siriwardana, Madunil Anuk Niriella, Anuradha Supun Dassanayake, Chandika Anuradha Habarakada Liyanage, Bhagya Gunetilleke, Hithanadura Janaka de Silva. Recurrence of graft steatosis after liver transplantation for cryptogenic cirrhosis in recently commenced liver transplant program. Indian Journal of Gastroenterology 2016; 35(3) doi: 10.1007/s12664-016-0653-0
|
| 135 |
Jie Yu, Xuesong Yang, Ya Luo, Xuefeng Yang, Mengxue Yang, Jin Yang, Jie Zhou, Feng Gao, Liting He, Jie Xu, Jonathan M. Peterson. Adverse effects of chronic exposure to nonylphenol on non-alcoholic fatty liver disease in male rats. PLOS ONE 2017; 12(7) doi: 10.1371/journal.pone.0180218
|